Lineage Cell Therapeutics, Inc. (LCTX)

1.73 -0.04 (-2.26%) USD  |  NYAM  |  Dec 18, 13:31
More

Lineage Cell Therapeutics EPS Basic from Continuing Operations (Quarterly)

EPS Basic from Continuing Operations (Quarterly) Chart

View EPS Basic from Continuing Operations (Quarterly) for LCTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Basic from Continuing Operations (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Basic from Continuing Operations (Quarterly) Range, Past 5 Years

View EPS Basic from Continuing Operations (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Basic from Continuing Operations (Quarterly) Benchmarks

View EPS Basic from Continuing Operations (Quarterly) Benchmarks
Start Trial
Ocugen, Inc. Upgrade
Belite Bio, Inc. Upgrade
CEL-SCI Corp. Upgrade
AIM ImmunoTech, Inc. Upgrade
IGC Pharma, Inc. Upgrade